BAY-38-7271

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBAY-38-7271
Drug Alias NameBAY-7271KN-38-7271BAY-38-7271
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonistsCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeyneurotekBayer AG
Active IndicationsN/A
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksWikipedia